Prosecution Insights
Last updated: May 04, 2026
Application No. 18/287,335

MICROSTRUCTURE FOR ACTIVELY SAMPLING MICROBE AND METHOD FOR ACTIVELY SAMPLING MICROBE BY USING SAME

Non-Final OA §112
Filed
Dec 13, 2023
Priority
Apr 23, 2021 — RE 10-2021-0052988 +1 more
Examiner
JANG, CHRISTIAN Y
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Daegu Gyeongbuk Institute Of Science And Technology
OA Round
1 (Non-Final)
69%
Grant Probability
Favorable
1-2
OA Rounds
1y 5m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allowance Rate
575 granted / 838 resolved
-1.4% vs TC avg
Strong +21% interview lift
Without
With
+20.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
28 currently pending
Career history
866
Total Applications
across all art units

Statute-Specific Performance

§101
15.4%
-24.6% vs TC avg
§103
37.2%
-2.8% vs TC avg
§102
16.2%
-23.8% vs TC avg
§112
22.6%
-17.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 838 resolved cases

Office Action

§112
DETAILED ACTION Claim Objections Claim 14 objected to because of the following informalities: "adsorbed by hydrogel" should be "adsorbed to a hydrogel" or "adsorbed by a hydrogel". Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 2, 12, and 14 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. As to claim 2, the claim recites the magnetic nanoparticles comprise at least one metal element selected from the group consisting of Fe, Ni, Pt, Au, Cr, Co, Gd, Dy, and Mn. However, Au (gold), Pt (platinum), Cr (chromium), and Mn (Manganese) are not considered to be magnetic. Thus it is unclear how a single metal element, which is within the recited scope of the claims, selecting one of the four metals above, could be considered magnetic nanoparticles. As to claim 12, the claim recites that the external stimulus is an alternating magnetic field (AMF) or near infrared (NIR). While the examiner notes that claim 12 is not dependent on claim 11, the only disclosed use for the external stimulus is to heat the magnetic nanoparticles and melt the fatty acid shell. However, near infrared has a penetration depth of roughly 5-10 mm, which is insufficient to reach the microstructure that must inherently be inside the subject (as claim 10 recites the discharge of the microstructure to an outside of the subject following the external stimulus). Further clarification is required and this claim may be subject to an enablement rejection if the external stimulus of near infrared is indeed correctly being recited. As to claim 14, the claim is currently dependent on claim 10, but should be dependent on claim 13 to provide antecedent basis for “the radical polymerization reaction”. Allowable Subject Matter Claims 1, 3-11, 13, and 15 are allowed. As to claim 1, the prior art of record fails to teach and/or fairly suggest, in combination with all other recited limitations, a microstructure comprising a core comprising magnetic nanoparticles and a shell surrounding the core comprising fatty acid. Waimin et al. ("Smart capsule for non-invasive sampling and studying of the gastrointestinal microbiome") teaches a device for sampling microbes within the gut using a hydrogel matrix (Abstract). Srivastava (US 2023/0181172) teaches an ingestible device for sampling of the gastrointestinal tract (Abstract) in which the hydrogel, by ways of a radical initiator and pre-polymer, is formed in situ ([0004]). Schreiber et al. (EP 2508171) teaches a chemical composition comprising a magnetic particle core comprising magnetic nano-particles ([0009]), the magnetic nano-particles being used to target specific locations within the body using an external magnetic field ([0010]), and a coating comprising a fatty acid ([0009]). Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTIAN JANG whose telephone number is (571)270-3820. The examiner can normally be reached Monday-Friday (7-3:30 EST). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Chen can be reached at 571-272-3672. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. CHRISTIAN JANG Primary Examiner Art Unit 3791 /CHRISTIAN JANG/Primary Examiner, Art Unit 3791 4/8/26
Read full office action

Prosecution Timeline

Dec 13, 2023
Application Filed
Apr 08, 2026
Non-Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12605092
INTERCONNECT FOR ON-BODY ANALYTE MONITORING DEVICE
4y 3m to grant Granted Apr 21, 2026
Patent 12593989
System and Method for Determining Vessel Size and/or Edge
3y 5m to grant Granted Apr 07, 2026
Patent 12582334
ANALYTE SENSOR DEVICES, CONNECTIONS, AND METHODS
3y 4m to grant Granted Mar 24, 2026
Patent 12575763
SYSTEMS, DEVICES, AND METHODS WITH DURATION-BASED ADJUSTMENT OF SENSOR DATA
3y 11m to grant Granted Mar 17, 2026
Patent 12575753
SKIN HYDRATION MEASUREMENT SYSTEM
1y 3m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
69%
Grant Probability
89%
With Interview (+20.8%)
3y 9m (~1y 5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 838 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month